project id: TCGA-UCEC; case submitter id: TCGA-AX-A3FX; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.7; rna integrity number: 8.1; age at index: 69; days to birth: -25260; days to death: 1333; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1940; age at diagnosis: 25260; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4.0; figo stage: Stage IIB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 736; initial weight: 100.0; oct embedded: false; preservation method: Unknown; sample id: 375bec4c-5e9b-4bc0-9f28-5854a159d655; sample submitter id: TCGA-AX-A3FX-01A; portion id: d49772ce-4577-43c4-977a-339b1b1c53e5; portion submitter id: TCGA-AX-A3FX-01A-11; slide id: e1d48480-d8f9-461f-8243-68a123363bfc; slide submitter id: TCGA-AX-A3FX-01A-01-TS1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 1.0; percent tumor cells: 92.0; percent tumor nuclei: 96.0; section location: TOP;